Cargando…
Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491060/ https://www.ncbi.nlm.nih.gov/pubmed/30658043 http://dx.doi.org/10.1513/AnnalsATS.201812-863OT |
_version_ | 1783414915399155712 |
---|---|
author | Nichols, Dave P. Durmowicz, Anthony G. Field, Ann Flume, Patrick A. VanDevanter, Donald R. Mayer-Hamblett, Nicole |
author_facet | Nichols, Dave P. Durmowicz, Anthony G. Field, Ann Flume, Patrick A. VanDevanter, Donald R. Mayer-Hamblett, Nicole |
author_sort | Nichols, Dave P. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6491060 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | American Thoracic Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-64910602019-05-10 Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities Nichols, Dave P. Durmowicz, Anthony G. Field, Ann Flume, Patrick A. VanDevanter, Donald R. Mayer-Hamblett, Nicole Ann Am Thorac Soc Perspective American Thoracic Society 2019-05 /pmc/articles/PMC6491060/ /pubmed/30658043 http://dx.doi.org/10.1513/AnnalsATS.201812-863OT Text en Copyright © 2019 by the American Thoracic Society http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/). For commercial usage and reprints, please contact Diane Gern (dgern@thoracic.org). |
spellingShingle | Perspective Nichols, Dave P. Durmowicz, Anthony G. Field, Ann Flume, Patrick A. VanDevanter, Donald R. Mayer-Hamblett, Nicole Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities |
title | Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities |
title_full | Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities |
title_fullStr | Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities |
title_full_unstemmed | Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities |
title_short | Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities |
title_sort | developing inhaled antibiotics in cystic fibrosis: current challenges and opportunities |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491060/ https://www.ncbi.nlm.nih.gov/pubmed/30658043 http://dx.doi.org/10.1513/AnnalsATS.201812-863OT |
work_keys_str_mv | AT nicholsdavep developinginhaledantibioticsincysticfibrosiscurrentchallengesandopportunities AT durmowiczanthonyg developinginhaledantibioticsincysticfibrosiscurrentchallengesandopportunities AT fieldann developinginhaledantibioticsincysticfibrosiscurrentchallengesandopportunities AT flumepatricka developinginhaledantibioticsincysticfibrosiscurrentchallengesandopportunities AT vandevanterdonaldr developinginhaledantibioticsincysticfibrosiscurrentchallengesandopportunities AT mayerhamblettnicole developinginhaledantibioticsincysticfibrosiscurrentchallengesandopportunities |